Vijaya Diagnostic Centre Limited (NSE:VIJAYA)
India · Delayed Price · Currency is INR 996.30
+5.00 (0.50%)
At close: Jan 23, 2026
Vijaya Diagnostic Centre Revenue
Vijaya Diagnostic Centre had revenue of 2.02B INR in the quarter ending September 30, 2025, with 10.17% growth. This brings the company's revenue in the last twelve months to 7.32B, up 16.71% year-over-year. In the fiscal year ending March 31, 2025, Vijaya Diagnostic Centre had annual revenue of 6.81B with 24.39% growth.
Revenue (ttm)
7.32B
Revenue Growth
+16.71%
P/S Ratio
14.01
Revenue / Employee
3.30M
Employees
2,218
Market Cap
102.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.81B | 1.34B | 24.39% |
| Mar 31, 2024 | 5.48B | 885.83M | 19.29% |
| Mar 31, 2023 | 4.59B | -31.47M | -0.68% |
| Mar 31, 2022 | 4.62B | 856.24M | 22.73% |
| Mar 31, 2021 | 3.77B | 379.25M | 11.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Divi's Laboratories | 100.29B |
| MedPlus Health Services | 62.93B |
| Indegene | 30.41B |
| Alivus Life Sciences | 24.81B |
| HealthCare Global Enterprises | 24.04B |